SitesBLAST
Comparing WP_005346963.1 NCBI__GCF_000173975.1:WP_005346963.1 to proteins with known functional sites using BLASTp with E ≤ 0.001.
Or try Sites on a Tree, PaperBLAST, Conserved Domains, or compare to all protein structures
Found 9 hits to proteins with known functional sites (download)
2qmxA The crystal structure of l-phe inhibited prephenate dehydratase from chlorobium tepidum tls (see paper)
38% identity, 69% coverage: 117:380/380 of query aligns to 4:273/278 of 2qmxA
- active site: T169 (= T285), F171 (= F287)
- binding phenylalanine: N204 (≠ H311), E205 (= E312), L209 (= L316), D222 (≠ N329), L223 (= L330), T224 (≠ S331), K225 (≠ H332), S228 (= S335), Y238 (= Y345), F240 (= F347)
P0A9J8 Bifunctional chorismate mutase/prephenate dehydratase; Chorismate mutase-prephenate dehydratase; P-protein; EC 5.4.99.5; EC 4.2.1.51 from Escherichia coli (strain K12)
27% identity, 97% coverage: 11:380/380 of query aligns to 10:375/386 of P0A9J8
- R11 (= R12) mutation R->A,K: Important decrease in catalytic efficiency and affinity.
- R28 (= R29) mutation R->A,K: Important decrease in catalytic efficiency and affinity.
- K39 (= K40) mutation K->A,Q,R: Important decrease in catalytic efficiency and affinity.
- E52 (= E53) mutation E->A,D,Q: Important decrease in catalytic efficiency and affinity.
- Q88 (= Q88) mutation Q->A,E,K: Important decrease in catalytic efficiency and affinity.
6vh5D Crystal structure of prephenate dehydratase from brucella melitensis biovar abortus 2308 in complex with phenylalanine
36% identity, 70% coverage: 116:380/380 of query aligns to 8:276/282 of 6vh5D
7am0B Gqqa- a novel type of quorum quenching acylases (see paper)
31% identity, 69% coverage: 117:380/380 of query aligns to 4:269/278 of 7am0B
- binding phenylalanine: N199 (≠ L310), N200 (≠ H311), Q201 (≠ E312), P202 (≠ S313), L205 (= L316), N218 (= N329), M219 (≠ L330), T220 (≠ S331), R221 (≠ H332), T234 (≠ Y345), F236 (= F347)
3mwbA The crystal structure of prephenate dehydratase in complex with l-phe from arthrobacter aurescens to 2.0a
30% identity, 68% coverage: 121:380/380 of query aligns to 7:274/306 of 3mwbA
3mwbB The crystal structure of prephenate dehydratase in complex with l-phe from arthrobacter aurescens to 2.0a
30% identity, 68% coverage: 121:380/380 of query aligns to 7:271/303 of 3mwbB
- active site: T176 (= T285), F178 (= F287)
- binding magnesium ion: A155 (= A264), Q158 (≠ L267), L161 (= L270)
- binding phenylalanine: D205 (≠ E312), H206 (vs. gap), L210 (= L316), N223 (= N329), L224 (= L330), S225 (= S331), R226 (≠ H332), I227 (= I333), Y236 (= Y345), F238 (= F347)
3luyA Putative chorismate mutase from bifidobacterium adolescentis
22% identity, 66% coverage: 116:364/380 of query aligns to 5:267/326 of 3luyA
5fiiB Structure of a human aspartate kinase, chorismate mutase and tyra domain. (see paper)
37% identity, 18% coverage: 303:372/380 of query aligns to 2:70/78 of 5fiiB
P00439 Phenylalanine-4-hydroxylase; PAH; Phe-4-monooxygenase; EC 1.14.16.1 from Homo sapiens (Human) (see 43 papers)
36% identity, 20% coverage: 298:372/380 of query aligns to 27:103/452 of P00439
- F39 (= F307) to L: in HPA and PKU; haplotype 1; dbSNP:rs62642926; natural variant: Missing (in PKU; haplotypes 9,21)
- L41 (= L309) to P: in PKU; mild; dbSNP:rs62642916
- K42 (≠ L310) to I: in PKU; haplotype 21; dbSNP:rs62635346
- G46 (= G314) to S: in PKU; haplotype 5; significantly reduces phenylalanine binding; dbSNP:rs74603784
- A47 (≠ T315) to V: in non-PKU HPA; haplotype 4; significantly reduces phenylalanine binding; dbSNP:rs118203925
- L48 (= L316) to S: in PKU; mild; haplotypes 3,4; dbSNP:rs5030841
- F55 (= F323) to L: in HPA and PKU; does not affect oligomerization; results in loss of substrate activation; dbSNP:rs199475598
- E56 (≠ L324) to D: in PKU; haplotype 10; dbSNP:rs199475567
- TH 63:64 (≠ SH 331:332) natural variant: TH -> PN (in PKU; haplotype 1; abolishes phenylalanine binding)
- I65 (= I333) to S: in PKU; results in disturbed oligomerization; results in loss of substrate activation; dbSNP:rs75193786; to T: in PKU; haplotypes 1,5,9,21,B; abolishes phenylalanine binding; dbSNP:rs75193786; to V: in HPA and PKU; dbSNP:rs199475643
- S67 (= S335) to P: in PKU; haplotype 4; dbSNP:rs5030842
- R68 (≠ V336) to S: in PKU; haplotype 1; dbSNP:rs76394784
- E76 (= E344) to G: in non-PKU HPA; dbSNP:rs62507347
- D84 (≠ N352) to Y: in PKU; haplotype 4; dbSNP:rs62514902
- S87 (≠ H356) to R: in non-PKU HPA; haplotype 1; dbSNP:rs62516151
- I94 (≠ A363) natural variant: Missing (in PKU; mild; haplotype 2)
- L98 (≠ V367) to S: in non-PKU HPA; dbSNP:rs62517167
Sites not aligning to the query:
- 16 modified: Phosphoserine; by PKA; S → P: in PKU; uncertain significance; dbSNP:rs62642946
- 104 A → D: in PKU; mild; haplotype 1; dbSNP:rs62642929
- 124 T → I: in PKU; haplotype 28; dbSNP:rs199475571
- 143 D → G: in PKU; haplotype 11; dbSNP:rs199475572
- 148 G → S: in PKU; haplotypes 1,2,7; dbSNP:rs80297647
- 151 D → H: in PKU; haplotypes 1,8; dbSNP:rs199475597
- 157 R → N: in PKU; severe; 5% activity; requires 2 nucleotide substitutions; dbSNP:rs1565853495
- 158 R → Q: in PKU; haplotypes 1,2,4,7,16, 28; dbSNP:rs5030843
- 161 F → S: in PKU; haplotype 4; dbSNP:rs79635844
- 164 I → T: in PKU; haplotype 1; dbSNP:rs199475595
- 170 H → Q: in PKU; does not affect oligomerization; dbSNP:rs199475652
- 171 G → A: in PKU; haplotype 1; dbSNP:rs199475596
- 173 P → T: in PKU; haplotype 4; dbSNP:rs199475574
- 174 I → T: in PKU; haplotype 1; dbSNP:rs138809906
- 176 R → L: in non-PKU HPA and PKU; dbSNP:rs74486803
- 177 V → L: in PKU; haplotype 6; dbSNP:rs199475602
- 178 E → G: in non-PKU HPA; dbSNP:rs77958223
- 190 V → A: in PKU; haplotype 3; dbSNP:rs62514919
- 201 H → Y: in non-PKU HPA; haplotype 1; dbSNP:rs62517205
- 204 Y → C: in PKU; mild; haplotypes 3,4; dbSNP:rs62514927
- 207 N → S: in PKU; severe; haplotype 4; dbSNP:rs62508721
- 211 P → T: in PKU; haplotype 4; dbSNP:rs62514931
- 213 L → P: in PKU; severe; dbSNP:rs62516109
- 218 G → V: in PKU; haplotypes 1,2; dbSNP:rs62514933
- 221 E → G: in PKU; haplotype 4; dbSNP:rs62514934
- 222 D → V: in PKU; haplotypes 3,4; dbSNP:rs62507319
- 224 I → M: in PKU; haplotype 4; dbSNP:rs199475576
- 225 P → T: in PKU; haplotype 1; dbSNP:rs199475589
- 230 V → I: in non-PKU HPA and PKU; haplotype 4; dbSNP:rs62516152
- 233 F → L: in PKU; haplotypes 2,3; dbSNP:rs62517208
- 238 T → P: in PKU; haplotype 4; dbSNP:rs199475577
- 241 R → C: in non-PKU HPA and PKU; haplotype 34; dbSNP:rs76687508; R → H: in PKU; haplotypes 1,5; dbSNP:rs62508730
- 243 R → Q: in non-PKU HPA and PKU; haplotypes 4,7,9; dbSNP:rs62508588
- 244 P → L: in PKU; haplotype 12; dbSNP:rs118203923
- 245 V → A: in PKU, HPA and non-PKU HPA; haplotypes 3,7; dbSNP:rs76212747; V → E: in PKU; haplotype 11; dbSNP:rs76212747
- 247 G → V: in PKU; haplotype 4; dbSNP:rs199475579
- 249 L → F: in PKU; haplotype 1; dbSNP:rs74503222
- 252 R → G: in PKU; haplotype 7; dbSNP:rs5030847; R → Q: in PKU; haplotype 1; dbSNP:rs62644503; R → W: in PKU; haplotypes 1,6,7,8,42, 69; complete loss of activity; dbSNP:rs5030847
- 255 L → S: in PKU; haplotype 36; dbSNP:rs62642930; L → V: in PKU; haplotypes 18,21; dbSNP:rs62642931
- 259 A → T: in PKU; haplotype 3; dbSNP:rs62642932; A → V: in PKU; haplotypes 7,42; dbSNP:rs118203921
- 261 R → Q: in HPA and PKU; mild; haplotypes 1,2,4,22, 24,28; dbSNP:rs5030849
- 269 I → L: in non-PKU HPA; dbSNP:rs62508692
- 270 R → S: in PKU; haplotype 1; dbSNP:rs62514951
- 273 S → F: in PKU; haplotype 7; dbSNP:rs62514953
- 275 P → L: in PKU; reduced activity; increased affinity for the substrate; mildly reduced substrate activation; decreased cofactor affinity; dbSNP:rs62508715
- 276 M → V: in PKU; haplotype 4; dbSNP:rs62516149
- 277 Y → D: in PKU; haplotype 2; dbSNP:rs78655458
- 280 E → K: in PKU; haplotypes 1,2,4,16,38; partial residual activity; dbSNP:rs62508698
- 281 P → L: in PKU; haplotypes 1,4; dbSNP:rs5030851
- 282 D → N: in PKU; haplotype 1; dbSNP:rs199475582
- 283 I → F: in PKU; haplotype 21; dbSNP:rs62517168; I → N: in PKU; severe; dbSNP:rs62508693; I→C: Loss of positive cooperativity and reduction of fold-activation by L-Phe preincubation.
- 297 R → C: in PKU; haplotype 4; dbSNP:rs62642945
- 299 F → C: in PKU; haplotype 8; dbSNP:rs62642933
- 300 A → S: in PKU and HPA; haplotype 1; does not affect oligomerization; reduction in activity is probably due to a global conformational change in the protein that reduces allostery; dbSNP:rs5030853
- 303 S → P: in PKU; haplotype 5; dbSNP:rs199475608
- 306 I → V: in non-PKU HPA and PKU; haplotype 4; dbSNP:rs62642934
- 309 A → D: in PKU; haplotype 7; dbSNP:rs62642935
- 310 S → F: in PKU; haplotype 7; dbSNP:rs62642913; S → Y: in HPA; reduction in activity is probably due to a global conformational change in the protein that reduces allostery; dbSNP:rs62642913
- 311 L → P: in PKU; haplotypes 1,7,10; dbSNP:rs62642936
- 314 P → S: in HPA; does not affect oligomerization; reduction in activity is probably due to a global conformational change in the protein that reduces allostery; dbSNP:rs199475650
- 318 I → T: in PKU; partial loss of activity; dbSNP:rs62642918
- 322 A → G: in PKU; haplotype 12; dbSNP:rs62514958; A → T: in PKU; haplotype 1; dbSNP:rs62514957
- 331 F → L: in PKU; haplotype 1; dbSNP:rs62517179
- 338 D → Y: in PKU; haplotype 4; dbSNP:rs62516150
- 342 A → T: in PKU; haplotype 5; dbSNP:rs62507282
- 345 A → T: in PKU; haplotype 7; dbSNP:rs62516062
- 348 L → V: in PKU; mild haplotype 9; dbSNP:rs62516092
- 349 S → L: in PKU; severe; dbSNP:rs62507279; S → P: in PKU; haplotypes 1,4; dbSNP:rs62508646
- 350 S → T: in PKU; haplotype 2; dbSNP:rs62517183
- 364 natural variant: Missing (in PKU; haplotype 5; dbSNP:rs62516096)
- 377 Y → C: in PKU; haplotype 4; dbSNP:rs62642942
- 380 T → M: in non-PKU HPA and PKU; haplotype 4; dbSNP:rs62642937
- 387 Y → H: in PKU; haplotype 1; dbSNP:rs62517194
- 388 V → M: in PKU; haplotypes 1,4; dbSNP:rs62516101
- 390 E → G: in PKU and non-PKU HPA; haplotype 4; dbSNP:rs5030856
- 395 A → P: in PKU; haplotype 1; dbSNP:rs62516103
- 403 A → V: in non-PKU HPA and PKU; haplotype 43; dbSNP:rs5030857
- 408 R → Q: in PKU; haplotypes 4,12; dbSNP:rs5030859; R → W: in HPA and PKU; haplotypes 1,2,4,5,13,34,41,44; most common mutation; reduction in activity is probably due to a global conformational change in the protein that reduces allostery; dbSNP:rs5030858
- 410 F → S: in PKU; mild; dbSNP:rs62644475
- 413 R → P: in non-PKU HPA and PKU; haplotype 4; dbSNP:rs79931499; R → S: in PKU; haplotype 1; dbSNP:rs62644467
- 414 Y → C: in HPA and PKU; haplotype 4; does not affect oligomerization; reduction in activity is probably due to a global conformational change in the protein that reduces allostery; dbSNP:rs5030860
- 415 D → N: in PKU, HPA and non-PKU HPA; haplotype 1; dbSNP:rs62644499
- 417 Y → H: in PKU; reduction in activity is probably due to a global conformational change in the protein that reduces allostery; dbSNP:rs62644471
- 418 T → P: in PKU; haplotype 4; dbSNP:rs62644501
Query Sequence
>WP_005346963.1 NCBI__GCF_000173975.1:WP_005346963.1
MDKEIRKVDDVRDDITKIDYEIAELFEKRMGFAAELALSKKQAGESIYNKNKEDEKLSDI
TKNRSNPFVIKGLEEVFIQMMSISRKYQYHMVHQRDRYIENYFTEVPELVMFPDTRIVYP
GVPGSFSEMACEKFFGADVDHYAVVNFKDVAMALNNGDADYGVLPIENSSAGDVTGVYDI
LLENDVCMVGEVFVKVEHCLLGCPGSKIEDLEVVLSHPQGLMQCAPYLENLDVKKVSVEN
TAIAAERVAREKIMTQGAIASRRAAELYGLDILDAGINFDKNNVTRFVILSKKRQYTENA
NKISISFSLLHESGTLYNILSHFLYNDLNLSHIESVPLPDQQWEYRFYIDINGNLHDPAV
KNALQGVRTEVADFKILGNY
Or try a new SitesBLAST search
SitesBLAST's Database
SitesBLAST's database includes
(1) SwissProt
entries with experimentally-supported functional features;
and (2) protein structures with bound ligands, from the
BioLip database.
by Morgan Price,
Arkin group
Lawrence Berkeley National Laboratory